BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4387723)

  • 21. Transmission of preganglionic impulses through the muscarinic receptors of the superior cervical ganglion of the cat.
    Trendelenburg U
    J Pharmacol Exp Ther; 1966 Dec; 154(3):426-40. PubMed ID: 5928243
    [No Abstract]   [Full Text] [Related]  

  • 22. Demonstration of central sympathetic excitation and inhibition on the nictitating membrane of the cat.
    Molnár J; György L; Unyi G
    Acta Physiol Acad Sci Hung; 1969; 36(1):137-55. PubMed ID: 5378639
    [No Abstract]   [Full Text] [Related]  

  • 23. Antagonism of the ganglion stimulating and parasympathetic actions of McN-A-343 by pilocarpine.
    Roszkowski AP; Misekova D; Volle RL; Hancock JC; Richards RK
    Arch Int Pharmacodyn Ther; 1971 Sep; 193(1):124-33. PubMed ID: 5111319
    [No Abstract]   [Full Text] [Related]  

  • 24. The action of morphine on the superior cervical ganglion and on the nictitating membrane of the cat.
    TRENDELENBURG U
    Br J Pharmacol Chemother; 1957 Mar; 12(1):79-85. PubMed ID: 13413156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Some pharmacological actions of 2-phenylquinoline methiodide.
    Di Gregorio GJ; Dipalma JR
    Br J Pharmacol Chemother; 1967 Aug; 30(3):531-40. PubMed ID: 4383092
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacological and electrophysiological analysis of the effects of nicotine on cat blood pressure.
    Koley J; Saha JK; Koley BN
    Arch Int Pharmacodyn Ther; 1987 May; 287(1):31-47. PubMed ID: 2888442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms involved in ganglionic blockade induced by tetramethylammonium.
    Gebber GL; Volle RL
    J Pharmacol Exp Ther; 1966 Apr; 152(1):18-28. PubMed ID: 4380009
    [No Abstract]   [Full Text] [Related]  

  • 28. The pharmacologic and toxicologic evaluation of the ganglionic blocking agent, dibutadiamin.
    McCarthy DA; Chen GM; Kaump DH; Potter D; Holappa KK; Ensor C
    Arch Int Pharmacodyn Ther; 1965 Apr; 154(2):263-82. PubMed ID: 4378730
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pharmacology of aphyllinic acid].
    Konovalova VA; Murtazaeva LV
    Farmakol Toksikol; 1971; 34(3):335-6. PubMed ID: 4398157
    [No Abstract]   [Full Text] [Related]  

  • 30. Ganglionic blocking action of some methylpiperidines.
    Vidal-Beretervide K; Monti JM; Ruggia R; Trinidad H
    J Pharmacol Exp Ther; 1966 May; 152(2):181-5. PubMed ID: 4380267
    [No Abstract]   [Full Text] [Related]  

  • 31. [Sympathetic ganglionic blocking actions of homotaurine and hexamethonium].
    Horii D; Takeuchi F; Shiono K; Ishii T
    Nihon Yakurigaku Zasshi; 1971 Nov; 67(6):564-71. PubMed ID: 4401053
    [No Abstract]   [Full Text] [Related]  

  • 32. Ganglion-blocking activity of bisquaternary ammonium salts derived from 3 ,12 -diamino-5 -cholane and 3 ,12 -diamino-24-nor-5 -cholane.
    Marshall IG; Martin-Smith M
    Eur J Pharmacol; 1972 Jan; 17(1):39-43. PubMed ID: 4401433
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacological studies on surugatoxin, the toxic principle from Japanese ivory mollusc (Babylonia japonica).
    Hayashi E; Yamada S
    Br J Pharmacol; 1975 Feb; 53(2):207-15. PubMed ID: 238699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of amidopyrine, antipyrine, analgine and sodium salicylate on the tonus of intracranial and extracranial vessels].
    Gaevyi MD
    Farmakol Toksikol; 1971; 34(2):174-81. PubMed ID: 5563387
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of the stimulating effects of nicotine, pilocarpine and histamine on the superior cervical ganglion of the cat.
    Iorio LC; McIsaac RJ
    J Pharmacol Exp Ther; 1966 Mar; 151(3):430-7. PubMed ID: 4380048
    [No Abstract]   [Full Text] [Related]  

  • 36. Interaction between angiotensin and neurally released norepinephrine on the cat nictitating membrane in vivo.
    Cervoni P; Reit E
    J Pharmacol Exp Ther; 1971 Dec; 179(3):543-54. PubMed ID: 4332751
    [No Abstract]   [Full Text] [Related]  

  • 37. Nicotinic and muscarinic activity of benzyltrimethyl-ammonium and its alpha-, beta- and gamma-substituted pyridylmethyltrimethylammonium analogs.
    Hamilton JT; Rubinstein HM
    J Pharmacol Exp Ther; 1968 Mar; 160(1):112-23. PubMed ID: 5639098
    [No Abstract]   [Full Text] [Related]  

  • 38. [Studies on the mechanism of the hypotensive action of monoaminoxidase inhibitors].
    Gawecka I; Gumulka W
    Acta Physiol Pol; 1965; 16(4):567-77. PubMed ID: 4223825
    [No Abstract]   [Full Text] [Related]  

  • 39. [Study of pharmacodynamic properties of cystamine and cysteamine in different animal species].
    Beaumariage ML; van Caneghem P; Bacq ZM
    Strahlentherapie; 1966 Nov; 131(3):342-51. PubMed ID: 4173210
    [No Abstract]   [Full Text] [Related]  

  • 40. Potentiation of actions of catecholamines by a derivative of hemicholinium.
    Wong S; Long JP
    J Pharmacol Exp Ther; 1967 Jun; 156(3):469-82. PubMed ID: 4381801
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.